Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar

Emerg Infect Dis. 2003 Feb;9(2):274-6. doi: 10.3201/eid0902.020128.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • Drug Resistance, Bacterial*
  • Ethambutol / pharmacology
  • Humans
  • Isoniazid / pharmacology
  • Myanmar / epidemiology
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification
  • Pyrazinamide / pharmacology
  • Rifampin / pharmacology
  • Streptomycin / pharmacology
  • Treatment Failure
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology*
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Pyrazinamide
  • Ethambutol
  • Isoniazid
  • Rifampin
  • Streptomycin